Search Browse Earnings

ANAPTYSBIO, INC

Nasdaq:ANAB

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ANAPTYSBIO, INC — SlamSEC

Revenue

$17.2M

+66.8% YoY

FY 2025

Adj. EBITDA

-$163.8M

-954.5% margin

FY 2025

Net Income

-$163.6M

-953.7% margin

FY 2025

EPS (Diluted)

-$6.08

FY 2025

Stock Price

$61.61

+11.2%

2026-03-10

52W Range

$15.32 – $63.47

P/E Ratio

-10.1x

Market Cap

$1.8B

Cash

$123.1M

FY 2025

Total Debt

$1.4M

FY 2020

Net Cash

$121.7M

FY 2020

Enterprise Value

$1.6B

Debt / EBITDA

0.7x

FY 2025

EV / EBITDA

-10.1x

Employees

—